Characteristics | No. cases | TBL1XR1 expression | Chi-square | |
---|---|---|---|---|
Low or none | High | Test P-value | ||
No. cases(%) | No. cases(%) | |||
Gender | ||||
Male | 79 | 41(51.9) | 38(48.1) | 0.611 |
Female | 26 | 12(46.2) | 14(53.8) | |
Age(years) | ||||
≤45 | 55 | 27(49.1) | 28(50.9) | 0.766 |
>45 | 50 | 26(52.0) | 24(48.0) | |
Clinical Stage | ||||
I | 2 | 2(100.0) | 0(0.0) | |
II | 21 | 18(85.7) | 3(14.3) | 0.001 |
III | 49 | 22(44.9) | 27(55.1) | |
IV | 33 | 11(33.3) | 22(66.7) | |
T classification | ||||
T1 | 3 | 3(100.0) | 0(0.0) | |
T2 | 32 | 21(65.6) | 11(34.4) | 0.040 |
T3 | 44 | 19(43.2) | 25(56.8) | |
T4 | 26 | 10(38.5) | 16(61.5) | |
N classification | ||||
N0 | 26 | 18(69.2) | 8(30.8) | |
N1 | 44 | 26(59.1) | 18(40.9) | 0.003 |
N2 | 22 | 5(22.7) | 17(77.3) | |
N3 | 13 | 4(30.8) | 9(69.2) | |
Patient survival | ||||
Alive | 59 | 39(66.1) | 20(33.9) | 0.001 |
Deceased | 46 | 14(30.4) | 32(69.6) |